Previous Article | Next Article ![]()
Journal of Virology, May 1999, p. 4485-4488, Vol. 73, No. 5
Lady Davis Institute for Medical Research and
McGill AIDS Centre,
Received 26 October 1998/Accepted 9 February 1999
During human immunodeficiency virus type 1 (HIV-1) assembly, the
primer tRNA for the reverse transcriptase-catalyzed synthesis of
minus-strand strong-stop cDNA, tRNA3Lys, is selectively
packaged into the virus and annealed onto the primer binding site on
the RNA genome. Annealing of tRNA3Lys in HIV-1 is
independent of polyprotein processing and is facilitated in vitro by p7
nucleocapsid (NCp7). We have previously shown that mutations in
clusters of basic amino acids flanking the first Cys-His box in NC
sequence inhibit annealing of tRNA3Lys in vivo by 70 to
80%. In this report, we have investigated whether these NC mutations
act through Pr55gag or
Pr160gag-pol. In vivo placement of
tRNA3Lys is measured with total viral RNA as the source
of primer tRNA-template in an in vitro reverse transcription assay.
Cotransfection of COS cells with a plasmid coding for either mutant
Pr55gag or mutant
Pr160gag-pol, and with a plasmid containing
HIV-1 proviral DNA, shows that only the NC mutations in
Pr55gag inhibit tRNA3Lys
placement. The NC mutations in Pr55gag reduce
viral infectivity by 95% and are trans-dominant-negative, i.e., they inhibit genomic placement of tRNA3Lys even
in the presence of wild-type Pr55gag. This
dominant phenotype may indicate that the mutant
Pr55gag is disrupting an ordered
Pr55gag structure responsible for the annealing
of tRNA3Lys to genomic RNA.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Role of Pr55gag in the
Annealing of tRNA3Lys to Human Immunodeficiency Virus
Type 1 Genomic RNA
*
Corresponding author. Mailing address: Lady Davis
Institute for Medical Research and McGill AIDS Centre, Jewish General
Hospital, Montreal, Quebec, Canada H3T 1E2. Phone: (514) 340-8260. Fax: (514) 340-7502. E-mail: md26{at}musica.mcgill.ca.
Journal of Virology, May 1999, p. 4485-4488, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|